BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33487098)

  • 1. Neurocognitive deficits in severe COVID-19 infection: Case series and proposed model.
    Whiteside DM; Oleynick V; Holker E; Waldron EJ; Porter J; Kasprzak M
    Clin Neuropsychol; 2021 May; 35(4):799-818. PubMed ID: 33487098
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive deficits in bipolar disorders: Implications for emotion.
    Lima IMM; Peckham AD; Johnson SL
    Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognition and psychological well-being in adults with post COVID-19 condition and analyses of symptom sequelae.
    Ashton Rennison VL; Chovaz CJ; Zirul S
    Clin Neuropsychol; 2024 Feb; 38(2):326-353. PubMed ID: 37350239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation.
    Negrini F; Ferrario I; Mazziotti D; Berchicci M; Bonazzi M; de Sire A; Negrini S; Zapparoli L
    Arch Phys Med Rehabil; 2021 Jan; 102(1):155-158. PubMed ID: 32991870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors.
    Méndez R; Balanzá-Martínez V; Luperdi SC; Estrada I; Latorre A; González-Jiménez P; Feced L; Bouzas L; Yépez K; Ferrando A; Hervás D; Zaldívar E; Reyes S; Berk M; Menéndez R
    J Intern Med; 2021 Sep; 290(3):621-631. PubMed ID: 33533521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocognitive Profiles in Patients With Persisting Cognitive Symptoms Associated With COVID-19.
    Krishnan K; Miller AK; Reiter K; Bonner-Jackson A
    Arch Clin Neuropsychol; 2022 May; 37(4):729-737. PubMed ID: 35136912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monthlong Intubated Patient with Life-Threatening COVID-19 and Cerebral Microbleeds Suffers Only Mild Cognitive Sequelae at 8-Month Follow-up: A Case Report.
    Backman L; Möller MC; Thelin EP; Dahlgren D; Deboussard C; Östlund G; Lindau M
    Arch Clin Neuropsychol; 2022 Feb; 37(2):531-543. PubMed ID: 34530432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic and cognitive sequelae after SARS-CoV2 infection: Different impairment for ICU patients.
    Mattioli F; Piva S; Stampatori C; Righetti F; Mega I; Peli E; Sala E; Tomasi C; Indelicato AM; Latronico N; De Palma G
    J Neurol Sci; 2022 Jan; 432():120061. PubMed ID: 34894422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up.
    Mazza MG; Palladini M; De Lorenzo R; Magnaghi C; Poletti S; Furlan R; Ciceri F; ; Rovere-Querini P; Benedetti F
    Brain Behav Immun; 2021 May; 94():138-147. PubMed ID: 33639239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Dysfunction, Psychiatric Distress, and Functional Decline After COVID-19.
    Vannorsdall TD; Brigham E; Fawzy A; Raju S; Gorgone A; Pletnikova A; Lyketsos CG; Parker AM; Oh ES
    J Acad Consult Liaison Psychiatry; 2022; 63(2):133-143. PubMed ID: 34793996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: Implications for the current COVID-19 pandemic.
    Rabinovitz B; Jaywant A; Fridman CB
    Clin Neuropsychol; 2020; 34(7-8):1453-1479. PubMed ID: 32901580
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropsychological Pattern in a Series of Post-Acute COVID-19 Patients in a Rehabilitation Unit: Retrospective Analysis and Correlation with Functional Outcomes.
    Di Pietro DA; Comini L; Gazzi L; Luisa A; Vitacca M
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34072951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.
    Kake TR; Garrett N; Te Aonui M
    Aust N Z J Psychiatry; 2016 Jun; 50(6):566-76. PubMed ID: 26494850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in post-acute sequelae of COVID-19 (PASC) at 6 months post-infection Part 1: Cognitive functioning.
    Whiteside DM; Basso MR; Naini SM; Porter J; Holker E; Waldron EJ; Melnik TE; Niskanen N; Taylor SE
    Clin Neuropsychol; 2022 May; 36(4):806-828. PubMed ID: 35130818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive abilities in children with adenotonsillar hypertrophy.
    Kurnatowski P; Putyński L; Lapienis M; Kowalska B
    Int J Pediatr Otorhinolaryngol; 2006 Mar; 70(3):419-24. PubMed ID: 16216342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive deficits predict poorer functional capacity in Huntington's disease: but what is being measured?
    Eddy CM; Rickards HE
    Neuropsychology; 2015 Mar; 29(2):268-73. PubMed ID: 25110931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histories of childhood maltreatment in schizophrenia: relationships with premorbid functioning, symptomatology, and cognitive deficits.
    Schenkel LS; Spaulding WD; DiLillo D; Silverstein SM
    Schizophr Res; 2005 Jul; 76(2-3):273-86. PubMed ID: 15949659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited evidence for neuropsychological dysfunction in patients initially affected by severe COVID-19.
    Priftis K; Velardo V; Vascello MGF; Villella S; Galeri S; Spada MS; Algeri L
    Neurol Sci; 2022 Dec; 43(12):6661-6663. PubMed ID: 36050424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.